A randomized, placebo- and sitagliptin-controlled trial of the safety and efficacy of omarigliptin, a once-weekly dipeptidyl peptidase-4 inhibitor, in Japanese patients with type 2 diabetes
2017 ◽
Vol 19
(11)
◽
pp. 1602-1609
◽
Ira Gantz
◽
Taro Okamoto
◽
Yuka Ito
◽
Kotoba Okuyama
◽
Edward A. O'Neill
◽
...
2020 ◽
Vol 22
(9)
◽
pp. 1659-1663
◽
Toru Kitazawa
◽
Hiroaki Seino
◽
Hiroshi Ohashi
◽
Takeshi Inazawa
◽
Masahiro Inoue
◽
...
2015 ◽
Vol 2
(3)
◽
pp. 1-6
2014 ◽
Vol 16
(8)
◽
pp. 761-765
◽
K. Kobayashi
◽
H. Yokoh
◽
Y. Sato
◽
M. Takemoto
◽
D. Uchida
◽
...
2020 ◽
Vol 15
(1)
◽
pp. e0228004
◽
Takeshi Onoue
◽
Motomitsu Goto
◽
Eri Wada
◽
Mariko Furukawa
◽
Takayuki Okuji
◽
...
2012 ◽
Vol 95
(2)
◽
pp. e27-e28
◽
Takashi Nomiyama
◽
Yuko Akehi
◽
Hiromasa Takenoshita
◽
Ryoko Nagaishi
◽
Yuichi Terawaki
◽
...
2014 ◽
Vol 16
(11)
◽
pp. 1078-1086
◽
G. Schernthaner
◽
A. H. Barnett
◽
S. Patel
◽
U. Hehnke
◽
M. von Eynatten
◽
...
Fukumi Yoshikawa
◽
Hiroshi Uchino
◽
Tomoko Nagashima
◽
Shuki Usui
◽
Masahiko Miyagi
◽
...
2020 ◽
Vol 11
(3)
◽
pp. 274-282
Yuichi Terawaki
◽
◽
Chikayo Iwaya
◽
Takashi Nomiyama
◽
Dai Shimono
◽
...
2010 ◽
Vol 57
(5)
◽
pp. 383-394
◽
Yasuhiko Iwamoto
◽
Tadaaki Taniguchi
◽
Kenji Nonaka
◽
Taro Okamoto
◽
Kotoba Okuyama
◽
...
2011 ◽
Vol 2
(2)
◽
pp. 94-105
◽
Masato Odawara
◽
Takashi Kadowaki
◽
Naoko Tajima
◽
Mikio Nishii
◽
Tadaaki Taniguchi
◽
...
Close
Export Citation Format
Close
Share Document
Close